Related Experiment Video

Updated: May 12, 2026

Using a Virtual Reality Walking Simulator to Investigate Pedestrian Behavior
06:38

Using a Virtual Reality Walking Simulator to Investigate Pedestrian Behavior

Published on: June 9, 2020

Low-speed vehicle run over fatalities in Australian children aged 0-5 years

Anne Paul Anthikkat1, Andrew Page, Ruth Barker

  • 1Discipline of Epidemiology and Biostatistics, School of Population Health, University of Queensland, Brisbane, Queensland, Australia.

Journal of Paediatrics and Child Health
|April 17, 2013
PubMed

Insights

Low-speed vehicle run over (LSVRO) incidents in Australia disproportionately affect young children, often occurring in residential driveways. Key risk factors include vehicle type and reversing maneuvers, highlighting areas for targeted prevention strategies.

Area of Science:

  • Pediatric Safety
  • Public Health Research
  • Injury Prevention

Background:

  • Low-speed vehicle run over (LSVRO) incidents represent a significant cause of mortality in young children.
  • Understanding the specific environmental and socio-demographic risk factors is crucial for developing effective prevention strategies.

Purpose of the Study:

  • To investigate environmental, socio-demographic, and antecedent risk factors associated with low-speed vehicle run over (LSVRO) mortality in Australian children aged 0-5 years.
  • To analyze trends in LSVRO incidence rates and identify modifiable factors contributing to these fatalities.

Main Methods:

  • A population-based retrospective case series study was conducted.
  • Data encompassed Australian LSVRO mortality from July 2000 to December 2010.
  • Mortality data were stratified by sex, age, period, area, location of injury, and mechanism.

Main Results:

  • Eighty-two fatal LSVRO cases were recorded over the 11-year period, with a declining incidence.
  • Over three-quarters of incidents occurred in non-traffic settings, primarily residential driveways, involving four-wheel drives or utilities, often reversing.
  • A higher proportion of fatalities occurred in lower socio-economic status areas, and drivers were often known to the child.

Conclusions:

  • LSVRO incidents in Australia disproportionately affect young children (≤36 months) and occur predominantly in residential driveways.
  • Modifiable antecedent factors, such as vehicle type and driver actions, were identified.
  • The study underscores the need for targeted prevention strategies and improved incident reporting.
Abstract

More Related Videos

Amplitude-Integrated EEG in Infants at Risk of Hypoxic-Ischemic Encephalopathy: A Feasibility Study in Road and Air Transport in Western Australia05:15

Amplitude-Integrated EEG in Infants at Risk of Hypoxic-Ischemic Encephalopathy: A Feasibility Study in Road and Air Transport in Western Australia

Published on: June 21, 2024

A Test Bed to Examine Helmet Fit and Retention and Biomechanical Measures of Head and Neck Injury in Simulated Impact07:30

A Test Bed to Examine Helmet Fit and Retention and Biomechanical Measures of Head and Neck Injury in Simulated Impact

Published on: September 21, 2017

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...